About Us
About Us
Contact Us
Letters to the editor
Advertise with us
Advertise with us
Atlanta Jewish Connector
Facebook
X (Twitter)
Newsletter
Publisher:
Michael Morris
Editor & Managing Publisher:
Kaylene Ladinsky
Keeping The Jewish Southeast Connected
JEWISH TIME PODCAST
SUBSCRIBE TODAY
search
Home
News
Arts
More
Education
Health and Wellness
Business
Israel
Sports
Opinion
Opinion
Jewish Time Podcast
Blogs
Events
Lifecycles
Obituaries
Births
Bar/Bat Mitzvahs
Weddings
Engagements
Anniversaries
Submit a Simcha
AJT Weekly
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Times of Israel Partner
search
Biogen
January 11, 2023, 12:17 pm
New Alzheimer’s Drug Gets FDA Approval
The drug, Leqembi, has shown some success in treating those who are in the early development stage of the disease.
By
Bob Bahr
July 14, 2021, 3:05 pm
Controversial New Alzheimer’s Drug Approved
Aduhelm is the first Alzheimer’s medication to slow the disease, but how the FDA approved the drug and its cost are the target of newly announced congressional hearings
By
Bob Bahr
Load More